Severity of Coronavirus Disease 2019 (COVID-19): Does Surfactant Matter?
Open Access
- 26 August 2020
- journal article
- editorial
- Published by Frontiers Media SA in Frontiers in Microbiology
Abstract
Severity of Coronavirus Disease 2019 (COVID-19): Does Surfactant Matter?Funding Information
- Deutsche Forschungsgemeinschaft
This publication has 46 references indexed in Scilit:
- Elevation of surfactant protein A in plasma and sputum in cigarette smokersEuropean Respiratory Journal, 2011
- Plasma Surfactant Protein D Levels and the Relation to Body Mass Index in a Chinese PopulationScandinavian Journal of Immunology, 2007
- The SARS coronavirus spike glycoprotein is selectively recognized by lung surfactant protein D and activates macrophagesImmunobiology, 2007
- Characterization of a human surfactant protein A1 (SP-A1) gene-specific antibody; SP-A1 content variation among individuals of varying age and pulmonary healthAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2007
- Surfactant Protein D of the Innate Immune Defence is Inversely Associated with Human Obesity and SP‐D Deficiency Infers Increased Body Weight in MiceScandinavian Journal of Immunology, 2006
- Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirusNature, 2003
- Surfactant protein-A enhances respiratory syncytial virus clearance in vivoJCI Insight, 1999
- Surfactant decreases pulmonary vascular resistance and increases pulmonary blood flow in the fetal lamb model of congenital diaphragmatic herniaJournal of Pediatric Surgery, 1996
- Age-dependency of surfactant phospholipids and surfactant protein A in bronchoalveolar lavage fluid of children without bronchopulmonary diseaseEuropean Respiratory Journal, 1996
- The Sex Difference in Fetal Lung Surfactant ProductionExperimental Lung Research, 1987